← Open Payments lookup

MEGHAN EGNER: Open Payments

NPI 1053067009 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,120 in 220 payments from 18 companies in 2025. Trend: 2023 $473 · 2024 $1,733 · 2025 $4,120

Food & beverage: $4,021Education: $99
CompanyPaymentsAmount
Janssen Biotech, Inc.58$1,063
ABBVIE INC.41$772
Madrigal Pharmaceuticals13$502
Salix Pharmaceuticals, a division of Bausch Health US, LLC27$339
Regeneron Healthcare Solutions, Inc.14$310
Takeda Pharmaceuticals U.S.A., Inc.18$205
Celltrion USA Inc.12$188
Ardelyx, Inc.9$159
Johnson & Johnson Health Care Systems Inc.1$133
Ipsen Biopharmaceuticals, Inc8$126

Products named: TREMFYA, REZDIFFRA, XIFAXAN, DUPIXENT, RINVOQ, LINZESS, VEGZELMA, IBSRELA.

Industry payments across PA — which companies pay providers there.